Title:
血液透析用剤に使用される造粒物、当該造粒物を含む血液透析用Ａ剤及び血液透析用剤
Document Type and Number:
Japanese Patent JP7372001
Kind Code:
B2
Abstract:
The purpose of the present invention is to provide a granulated material for a hemodialysis agent that contains an acetic acid salt and magnesium chloride and/or calcium chloride and has excellent storage stability. A granulated material to be used in a hemodialysis agent, said granulated material comprising a core particle and a coating formed on at least a part of the surface of the core particle, wherein the core particle contains an acetic acid salt and is substantially free of sodium chloride, and the coating contains magnesium chloride and/or calcium chloride.
Inventors:
Ryota Nakama
Yoshinori Yoshimoto
Yasutaka Fujii
Yoshinori Yoshimoto
Yasutaka Fujii
Application Number:
JP2023537456A
Publication Date:
October 31, 2023
Filing Date:
October 11, 2022
Export Citation:
Assignee:
Tomita Pharmaceutical Co., Ltd.
International Classes:
A61K47/02; A61K9/08; A61K9/16; A61K31/19; A61K31/7004; A61K33/14
Domestic Patent References:
| JP2016209485A | ||||
| JP2016112062A | ||||
| JP2008303151A | ||||
| JP2002291878A |
Foreign References:
| WO2018079022A1 |
Attorney, Agent or Firm:
Junya Tanaka
Kaguya Mizutani
Kaguya Mizutani
Previous Patent: Lighting device control system and lighting device control method
Next Patent: hard coating
Next Patent: hard coating